Company Filing History:
Years Active: 2014-2017
Title: Innovations by Xiaobin Deng in Cancer Treatment
Introduction
Xiaobin Deng is a prominent inventor based in Guangzhou, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 4 patents, his work focuses on targeted therapies that aim to improve patient outcomes in oncology.
Latest Patents
Deng's latest patents include groundbreaking compounds and methods for the treatment of ERB B2/NEU positive diseases. One of his notable inventions involves anti-ERB B2/NEU antibodies conjugated with maytansinoid drugs for targeted delivery to disease tissues. This method provides a novel approach to treating ERB B2/NEU positive cells in cancers. Additionally, he has developed maytansinoid drug linker derivatives that can be linked to an antigen binding unit. These drug conjugates are designed for targeted delivery to disease tissues, offering potential treatments for antigen positive cells in cancers and immunological disorders.
Career Highlights
Xiaobin Deng is currently associated with Bio-Thera Solutions, Ltd., Co., where he continues to advance his research in cancer therapies. His work has garnered attention for its innovative approach to drug delivery and treatment efficacy.
Collaborations
Deng collaborates with esteemed colleagues such as Weijia Tang and Songnuan Tan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Xiaobin Deng's contributions to cancer treatment through his patents and research exemplify the impact of innovation in medicine. His work continues to pave the way for new therapeutic strategies that could significantly benefit patients facing challenging diagnoses.